🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
The purpose of this study is to evaluate the efficacy and safety of divaras...
Status
Recruiting
Location
Alaska Oncology and Hematology
Start Date
2025-10-24
Trial ID
NCT06793215
Treatments Being Tested
Immunotherapeutic approaches recently have demonstrated clinical efficacy i...
Status
Recruiting
Location
Aix-en-Provence - CH
Start Date
2022-05-02
Trial ID
NCT05255302
Treatments Being Tested
This ALCHEMIST trial studies genetic testing in screening patients with sta...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-09-26
Trial ID
NCT02194738
Treatments Being Tested
This is a study to assess the efficacy and safety of pembrolizumab (MK-3475...
Status
Completed
Location
Multiple Locations
Start Date
2014-08-25
Trial ID
NCT02142738
Treatments Being Tested
An open-label, single institutional phase II trial of losartan in patients ...
Status
Unknown
Location
Oslo University Hospital
Start Date
2019-10-01
Trial ID
NCT03951142
Treatments Being Tested
The purpose of this platform study is to evaluate the safety, tolerability,...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2024-01-18
Trial ID
NCT06162221
Treatments Being Tested
This was an open-label, nonrandomized, Phase 1/2 study designed to determin...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2017-05-02
Trial ID
NCT03085914
This is an open-label, multicenter, extension study. Patients who are recei...
Status
Active Not Recruiting
Location
University of Colorado Cancer Center
Start Date
2019-02-28
Trial ID
NCT03768063
The purpose of this study is to assess the safety and efficacy of pemetrexe...
Status
Completed
Location
Chiba University Hospital
Start Date
2022-07-01
Trial ID
NCT05258279
Treatments Being Tested